KOTAI Biotechnologies, Inc

Ibaraki, Japan

Visit website

The repertoire of immune cell receptors has direct consequences for resistance to infection, autoimmune disease and cancer.

KOTAI’s platform technology can reveal the structure and function of immune cell receptors with unprecedented resolution from a routine blood sample.

Our vision is to provide technology that reveals the functional state of the immune system at the molecular level.

The only high-throughput structural modeling and analysis platform for immune cell sequences.

ACCURACY
Our B and T cell receptor modeling technology is the most accurate available. Typical errors for backbone residues is less than 1 Angstrom.
SPEED
The current version of Repertoire Builder produces 1,000 models per day on a single processor, and scales linearly with the number of processors.
SOPHISTICATION
Using sequence and structural features from B or T cell receptor models, Repertoire Builder can group receptors according to their target epitopes, revealing the functional landscape of a donor and quantifying differences between donors.

Wenzhou-Kean University China 14 open positions

University of Nizwa Nizwá, Oman 7 open positions

RMIT International University Vietnam (RMIT Vietnam) Ho Chi Minh City, Vietnam 7 open positions

American University of Iraq - Baghdad Baghdad, Iraq 4 open positions

KIMEP University Almaty, Kazakhstan 2 open positions

5 Reasons to Pursue Your PhD at EMBL European Molecular Biology Laboratory (EMBL) 4 min read

The genetic detectives discovering who we really are University of Turku 5 min read

Deciphering the Gut’s Clues to Our Health University of Turku 5 min read

Understanding Users to Optimise 3D Experiences Centrum Wiskunde & Informatica (CWI) 5 min read

Harnessing the Rhizosphere to Protect Our Soil Free University of Bozen - Bolzano 5 min read